LXRX - Lexicon Pharmaceuticals Inc. (LXRX) CEO Lonnel Coats on Q4 2020 Results - Earnings Call Transcript
Lexicon Pharmaceuticals, Inc. (LXRX) Q4 2020 Results Conference Call March 10, 2021 5:00 PM ET Company Participants Chas Schultz - Executive Director of Corporate Communications & Patient Advocacy Lonnel Coats - President and Chief Executive Officer and Director Praveen Tyle - Executive Vice President of Research and Development Jeff Wade - Executive Vice President, Corporate and Administrative Affairs and Chief Financial Officer Conference Call Participants Carly Kenselaar - Citigroup Stephen Willey - Stifel Yuko Oku - JPMorgan Kevin Kedra - G. Research Joseph Stringer - Needham & Company Presentation Operator Good afternoon. My name is Chantal, and I'll be your conference operator today. At this time, I would like to welcome everyone to Lexicon Pharmaceuticals Fourth Quarter 2020 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session. [Operator Instructions]. Please be advised that today's conference
For further details see:
Lexicon Pharmaceuticals, Inc. (LXRX) CEO Lonnel Coats on Q4 2020 Results - Earnings Call Transcript